MED director reports nearly $1M open-market purchase
The substantial reported purchase, alongside another recent purchase by the same director, is a notable positive insider signal, though it does not establish future performance.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The substantial reported purchase, alongside another recent purchase by the same director, is a notable positive insider signal, though it does not establish future performance.
What happened, with direct paths to the underlying reporting
Director Kiai Parsa reported purchasing 82,700 MED shares for about $996,237 at $12.05. A separate purchase by the same director the prior day was reported at about $104,952, adding to the positive insider-buy signal.
Insider: Kiai Parsa
Role: director
Transaction: P-Purchase
Shares: 82,700
Price: $12.05
Value: $996,237
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.